share_log

复星医药关于控股子公司获药品临床试验批准的公告

Announcement of Fosun Pharmaceutical on the approval of its holding subsidiary for drug clinical trials

SZSI ·  Sep 27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more